Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd

¥23.89As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301130Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (19.39%)
Div yield 0.61%
ROE (0.70%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.59
PE TTM —
TSR TTM (22.46%)
Mkt cap ¥1.804B
ROIC (1.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥26
9.31%
(81.66%)
Hold 11|4|1|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.38
0.37
0.41
0.41
18.78%
4.59%
11.73%
15.50%
Revenue¥M
136.9
134.7
142.2
142.1
(0.30%)
(0.32%)
4.68%
1.03%
Peers (US$270.4M)
Cap (US$)
PE
281.3M
—
275.7M
29.33x
267.6M
32.86x
Capital
TTM
5Y
10Y
Leveragex
0.754
0.142
0.146
EBIT/Intx
0.315
0.399
0.384
Own earn%
(46.42)
126.23
124.55
Sh yield%
30.27
11.19
8.91
Owners
Insiders/Inst%
8.74
60.03
Short interest%
5.85
SBC / revenue%
2.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
9–15
$1 testx
0.0
Incr. ROIC%
6